Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-03-10

FDA Approved: EVOMELA — Original Application (Acrotech Biopharma Inc)

View source ↗

Summary

FDA approved EVOMELA (melphalan liposome injection) from Acrotech Biopharma as the original application, providing the first approval of this liposomal melphala…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EVOMELA (melphalan hydrochloride)

Snippet

ORIG AP for EVOMELA (MELPHALAN)